CORONARY DILATATION CATHETER
- UID
- IMP/MD/2023/000509_c238fe24f8f241a0ed7348748c266705_cd1540fd9fac4fc77c3ba28ac665231d
- Device class
- Class C
- Brand name
- NC TREK NEO™
- License holder
- Abbott Healthcare Private Limited
- Approving authority
- CDSCO
- Product information
- The NC TREK NEO™ Coronary Dilatation Catheters are indicated for: a) Balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis, for the purpose of improving myocardial perfusion b) Balloon dilatation of a coronary artery occlusion, for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction c) Balloon dilatation of a stent after implantation (NC TREK NEO™)
CORONARY DILATATION CATHETER is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2023/000509_c238fe24f8f241a0ed7348748c266705_cd1540fd9fac4fc77c3ba28ac665231d. This device is marketed under the brand name NC TREK NEO™. The license holder is Abbott Healthcare Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.